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The elastic properties of membrane bilayers are key parameters that control its deformation and can be affected by pharmacological agents. Our
previous atomic force microscopy studies revealed that the macrolide antibiotic, azithromycin, leads to erosion of DPPC domains in a fluid DOPC
matrix [A. Berquand, M. P. Mingeot-Leclercq, Y. F. Dufrene, Real-time imaging of drug-membrane interactions by atomic force microscopy,
Biochim. Biophys. Acta 1664 (2004) 198-205.]. Since this observation could be due to an effect on DOPC cohesion, we investigated the effect of
azithromycin on elastic properties of DOPC giant unilamellar vesicles (GUVs). Microcinematographic and morphometric analyses revealed that
azithromycin addition enhanced lipid membranes fluctuations, leading to eventual disruption of the largest GUVs. These effects were related to
change of elastic moduli of DOPC, quantified by the micropipette aspiration technique. Azithromycin decreased both the bending modulus (kc, from
23.1±3.5 to 10.6±4.5 kBT) and the apparent area compressibility modulus (Kapp, from 176±35 to 113±25 mN/m). These data suggested that
insertion of azithromycin into the DOPC bilayer reduced the requirement level of both the energy for thermal fluctuations and the stress to stretch the
bilayer. Computer modeling of azithromycin interaction with DOPC bilayer, based on minimal energy, independently predicted that azithromycin (i)
inserts at the interface of phospholipid bilayers, (ii) decreases the energy of interaction between DOPCmolecules, and (iii) increases the mean surface
occupied by each phospholipid molecule. We conclude that azithromycin inserts into the DOPC lipid bilayer, so as to decrease its cohesion and to
facilitate the merging of DPPC into the DOPC fluid matrix, as observed by atomic force microscopy. These investigations, based on three
complementary approaches, provide the first biophysical evidence for the ability of an amphiphilic antibiotic to alter lipid elastic moduli. This may be
an important determinant for drug: lipid interactions and cellular pharmacology.
© 2007 Elsevier B.V. All rights reserved.Keywords: Micropipette; Giant vesicle; Bending modulus; Area compressibility modulus; Azithromycin; DOPC1. Introduction
Interactions of drugs with biological membranes may
account for their activity and/or toxicity, thus represent an
important area of investigation. Artificial lipid bilayers are
increasingly used as models of cell membranes for biophysical
studies of lipid:lipid, lipid:protein, and lipid:drug interactions.⁎ Corresponding author. Tel.: +32 2 764 73 74; fax: +32 2 764 73 73.
E-mail address: mingeot@facm.ucl.ac.be (M.-P. Mingeot-Leclercq).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.04.013Using atomic force microscopy on supported artificial phos-
pholipid bilayers, we showed that azithromycin, a macrolide
dicationic antibiotic [2,3] (Fig. 1), not only leads to the erosion
and eventual disappearance of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) gel phase domains surrounded by a
fluid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)matrix,
but also increases the fluidity at the hydrophilic/hydrophobic
interface of DOPC:DPPC [1,4]. To test whether these alterations
resulted from changes in membrane cohesion of the bulk lipid
phase, we here addressed the effect of azithromycin on the elastic
properties of DOPC bilayers.
Fig. 1. Structural formula of azithromycin (9-deoxo-9a-methyl-9a-azahomoer-
ythromycin A).
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efforts have been devoted over the last three decades to determine
the biophysical parameters of membrane cohesion and elasticity,
in particular the bending properties which control bilayer fluc-
tuations and vesicle shape in relation to intrinsic bilayer pro-
perties such as adhesion, in- or e-vagination and lipid: protein
interactions [7–9]. The two major parameters reflecting the
elastic properties of a bilayer are the bending modulus (kc),
reflecting the energy associated to spontaneous thermal fluctua-
tions of the membrane, and the apparent area compressibility
modulus (Kapp), reflecting the energy required to stretch a bilayer.
In present work, we used giant unilamellar vesicles (GUVs)
made of DOPC to study the effect of azithromycin on the
overall shape of vesicles, and to measure the bending modulus
and the apparent area compressibility modulus by the micro-
pipette aspiration technique [10,11]. Results were related to the
location of azithromycin at the hydrophilic/hydrophobic inter-
face, the mean surface occupied by each DOPC molecule and
the energy of interaction between DOPC molecules as deter-
mined by molecular modeling.
2. Materials and methods
2.1. Reagents
DOPC was purchased from Avanti Polar Lipids (Alabaster, AL, USA) and
used without further purification; Tris (Tris-hydroxymethyl-aminomethane) was
from Merck (Darmstadt, Germany). Bovine serum albumin (BSA), glucose and
sucrose were from Fluka (Buchs, Switzerland). Azithromycin (potency=94.4%,
MW=785 g/mol) was supplied as dihydrate free base by Pfizer (Groton, CT,
USA). Since azithromycin is sparingly soluble in water at pH 7.0, but very
soluble at acidic pH, a stock solution was prepared by dissolving 22.5 mg of the
free base in 1 ml 0.1 M HCl (28.6 mM) and further diluted in Tris buffer
(10 mM, pH 7.4) or in Milli-Q water just before the experiments, as indicated.
2.2. GUVs preparation
DOPC-GUVs were prepared by electroformation [12]. Ten μl of a DOPC
solution (1 mg/ml in CHCl3) were spread onto the Indium Tin Oxide (ITO)-coated side of a glass slide, followed by vacuum drying overnight. A growing
chamber for vesicle electroformation was mounted by placing a covering plate
over the conductive glass slide containing the lipidic film and by sealing both
plates to each other with Vitrex wax (Vitrex, Denmark) with a 1-mm spacer. For
direct morphological studies, the lipid film was hydrated with a 100 mM sucrose
solution. For micropipette aspiration studies, the lipid film was hydrated with
100 mM sucrose supplemented or not with azithromycin solution (50 μM, final
concentration). For both studies, GUVs were grown by applying an alternative
voltage (2 V, 10 Hz) across the growing chamber for about 1 h.
2.3. Transfer of GUVs
Giant vesicles were transferred either into an observation chamber or a
manipulation chamber filled with 102 mM glucose. The slight density difference
between the 100 mM sucrose and 102 mM glucose solutions drived the vesicles
toward the bottom plate where they could be easily handled and observed. The
glucose and sucrose concentrations osmotically matched the outer and inner
solutions (Osmometer Knauer, Osmo 2320, Berlin, Germany), so as to avoid
vesicle swelling or shrinkage. A thin glass slide covered the spacer to avoid
evaporation. In such conditions, GUVs were stable during at least 1 day [13].
For the observation of GUVs, we used a chamber made of a glass slide with
a spacer (CoverWell, Grace Bio-Labs, Bend, OR, USA). To test the effect of
azithromycin, the cavity of the chamber was filled with a mixture of 100 μl of
GUVs suspension in 102 mM glucose and 30 μl of a solution containing glucose
and azithromycin, to reach a final 50 μM azithromycin concentration. Since not
all lipid initially deposited on the ITO-coated slide becomes organized in giant
vesicles, it was not possible to evaluate either the exact amount of phospholipid
transferred in the observation or manipulation chambers, nor the DOPC:azith-
romycin ratio.
For GUVs handling, we used a manipulation chamber made of a thin glass
slide with a spacer (CoverWell). The inner volume of the spacer was around
0.6 ml. Hundred μl of a vesicle suspension were transferred from the growing
chamber to the manipulation chamber containing 0.5 ml of a 102 mM glucose
solution. To prevent leakage of azithromycin entrapped in GUVs during their
preparation, azithromycin was added to the manipulation chamber to a final
25 μM concentration. For micromanipulation of GUVs in presence of azith-
romycin, the stock antibiotic solution was diluted in water instead of Tris buffer,
in order to minimize charges in the manipulation chamber.
2.4. Morphological studies
Several hundreds of GUVs, preincubated or not with 50 μM azithromycin
for 30 min, were recorded with an inverted microscope (Axiovert S100, Zeiss,
Germany) to determine the vesicle size distribution (Axiovision 4.4 program,
Zeiss, Göttingen, Germany). Briefly, after recording grey level images, indi-
vidual objects were resolved by segmentation (binary images: white GUVs on a
black background) and residual open structures were filled. Surfaces of indi-
vidual GUVs were measured together with a shape factor (circle=1; line=0).
Only GUVs with a shape factor N0.9 and a surface N8 pixels2 (5.7 μm2) were
retained for the analysis. Each processed image was inspected one by one to
ensure the complete and exclusive selection of GUVs (97% of recorded GUVs
satisfied these criteria). The morphometric analysis was performed by an
independent investigator, unaware of GUVs treatment.
2.5. Micropipette aspiration of GUVs
The bending modulus and the apparent area compressibility modulus were
determined by controlled aspiration of GUVs into micropipettes made by
pulling borosilicated capillary glass tubing (Phymep, Paris, France) with a
microforge (F-1200, de Fonbrune, Alcatel, France). To avoid charge accumu-
lation on the glass, the micropipette and the glass slide at the bottom of the
manipulation chamber were first pretreated with a 0.05% (w/w) BSA solution in
water during 10 min, then rinsed with distilled water to remove unbound BSA.
The micropipette, with a final diameter of ∼10 μm, was fixed on the stage of an
inverted microscope and was driven by a xyz shift with an AIS2 micromani-
pulator device (CellBiology Trading, Hamburg, Germany) to contact selected
vesicles. Then, a pressure difference between the interior and the exterior of the
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micrometer (DMH-1, Newport Corporation, Irvine, CA, USA), with an accuracy
of 10 mPa. Images of GUVs were obtained with a C5405 camera (Hamamatsu,
Japan) using a 40× magnification and analyzed with the AIS2 software.
2.6. Determination of the bending modulus (kc) and the apparent area
compressibility modulus (Kapp).
The relation between the apparent surface change area (α) and the tension of
the membrane (σ) was determined using a micropipette apparatus, as first
developed by Evans [10,14] to extract both kc and Kapp moduli. These biophy-
sical measurements of the membrane mechanical intrinsic properties were used
to quantify alterations induced by azithromycin. The α and σ parameters were
determined as follows: a cylindrical micropipette of internal radius r held a
vesicle with a pressure difference ΔP=Pi−Pe, where Pi and Pe are the inner
and outer micropipette pressure, respectively (Fig. 2). Aspiration of the vesicle,
originally a sphere of radius R, generated a cylindrical component of length L
and a hemispherical cap of radius r. The radius of the remaining vesicle outside
of the micropipette decreased to R.
Laplace's law allows one to determine the tension, σ, from these geometrical
values:
r ¼ DP
2
r
1 ðr=RÞ
 
ð1Þ
Parameter α is defined as the relative increase of the apparent area of the
vesicle, from an initial state Aa,0, when the vesicle was submitted to some
minimal pressure difference ΔP0, to a final state Aa corresponding to a given
pressure difference ΔP:
a ¼ Aa  Aa;0
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2
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The fundamental constitutive equation of fluid bilayers, established by
Helfrich [5], reads:
A Aa
Aa
¼ kBT
8pkc
ln
r
r0
þ Kapp
r
ð3Þ
where kB is the Boltzmann constant, T is the absolute temperature in Kelvin
degrees, σ0 is a reference value of the tension for each vesicle, A is the actual
area of the lipid vesicle, kc is the bending modulus and Kapp is the apparent area
compressibility modulus.Fig. 2. Typical image of a giant unilamellar vesicle (R=23.8μm) under contact and
minor suction by the micropipette (r=9.6 μm). Tension (σ) was 1.3.10−7 N/m and
pressure difference (ΔP=Pe−Pi) was 0.3 Pa.The Helfrich's law (Eq. (3)) then becomes:
a ¼ kBT
8pkc
ln
r
r1
þ Kapp
r
ð4Þ
where σ1 is the value of the first measured tension. In the low σ regime, some of
the real area A was hidden in sub-optical fluctuation modes and only the
apparent projected area Aa could be optically measured. Thus, a plot of the
natural logarithm of the tension, σ as a function of α for successive values of the
pressure differences ΔP, allowed one to derive kc. In the high σ regime, the
bilayer was extended in the lateral dimension, and a plot of σ as a function of α
allowed for the calculation of Kapp.
2.7. Interaction between azithromycin and phospholipids by molecular
modeling using the Hypermatrix procedure
The Hypermatrix procedure was used to study the interaction between
azithromycin andDOPCmolecules, as previously described [15]. In this method,
the lipid:water interface is modelised by linearly varying the dielectric constant
ε between 3 (above the interface) and 30 (below the interface). The initial
position and orientation of azithromycin and the lipids are those defined using
the TAMMO procedure, taking into account the hydrophobic and hydrophilic
centers of the molecule [15].
The position of azithromycin was kept constant and parallel to Y axis while
the first lipid molecule translated towards the azithromycin molecule along the
axis by l steps of 0.1 nm. It rotated by steps of 10° around its Z′ axis and around
the X axis: l is the number of positions tested along the X axis,m is the number of
rotations around azithromycin and n is the number of rotations around the lipid
itself. For each set of l, m and n values, the energy of interaction between
azithromycin and lipid was calculated as the sum of Van der Waals, electrostatic
and hydrophobic terms. Then, for each set of values l,m and n, the lipid molecule
moved by step of 0.05 nm along the Z′ axis perpendicular to the interface and the
angle of Z′ axis bended by +1.5° with respect to the Z axis. The energy values
together with the co-ordinates of all assemblies were stored in a matrix and
classified according to decreasing values. The most stable matching was selected
to set the position of the first lipid. The position of the second lipid was then
defined as the next most energetically favourable orientation stored in the
hypermatrix, taking steric and energetic constraints due to the presence of the first
lipid molecule into account. To further minimize the energy of the tri-complex,
the position of both lipid molecules was alternatively modified according to the
energy classification of the hypermatrix. For the next lipid molecule, the same
process was iterated but the positions of all surrounding molecules were alter-
natively modified in order to derive the lowest energy state. In these calculations,
the energy of interaction between all lipids is minimized. The process was ended
when azithromycin was completely surrounded with lipids.
The azithromycin:DOPC assembly was then inserted into an implicit sim-
plified bilayer using the IMPALA method described previously [16]. This
method simulates the insertion of any molecule into a bilayer by adding energy
restrain functions to the usual energy description of molecules. The lipid bilayer
was defined by C(z), which represents an empirical function describing mem-
brane properties. This function is constant in the membrane plane (X and Yaxes)
but varies along the bilayer thickness (Z axis) and more specifically, at the lipid:
water interface corresponding to the transition between lipid acyl chains (no
water=hydrophobic core) and the hydrophilic aqueous environment:
CðzÞ ¼ 1 11þ eaðzz0Þ
where α is a constant equal to 1.99; z0 corresponds to the middle of polar heads
and z is the position in the membrane.
Two restraints were imposed to simulate the lipid membrane properties: the
bilayer hydrophobicity (Epho) and the lipid perturbation (Elip).
The hydrophobicity of the membrane is simulated by Epho :
Epho ¼ 
XN
i¼1
SðiÞEtrð iÞCðziÞ
where N is the total number of atoms, S(i) the accessible surface to solvent of the
i atom, Etr(i) its transfer energy per unit of accessible surface area and C(zi) the zi
position of atom i.
Fig. 3. Qualitative evidence for the destabilization of GUVs by azithromycin. Typical fluctuations of a GUV exposed to 50 μM azithromycin over 30 s. Scale
bar=20 μm.
Fig. 4. Effect of azithromycin on the size distribution of GUVs. GUVs were incubated for 30 min in a glucose solution without (A) or with 50 μM azithromycin (B).
Scale bar=50 μm. (C) Quantification of the distribution of projected area for control (open bars) and azithromycin-treated GUVs (filled bars) with class intervals of
70 μm2. The size distributions were calculated on 530 control and 606 azithromycin-treated GUVs. Bars are centered on the middle of each interval. Azithromycin
significantly altered the GUVs distribution, as shown by the Kolmogorov–Smirnov test (pb0.0001).
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Fig. 5. Tension (ln σ) versus area increase (α) for control (open symbols) or
azithromycin-treated GUVs (filled symbols) at σb0.5 mN/m (A) or N0.5 mN/m
(B). The bending modulus (kc) and the apparent area compressibility modulus
(Kapp) were calculated from the slope of the linear components, represented as
straight lines based on Eq. (4). Typical results obtained for one representative out
of 25 control and 40 azithromycin-treated GUVs.
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the lipid perturbation restraint (Elip):
Elip ¼ alip
XN
i¼1
SðiÞð1 CðziÞÞ
where alip is an empirical factor fixed at 0.018 kcal mol
−1 Å−2.
The environment energy (Eenv) applied on the drug that inserts into the
membrane becomes equal to:
Eenv ¼ Epho þ Elip
Calculations were performed on an Intel® Pentium® 4, CPU 3.80 GHz, 4.00
Go of RAM, using Z-TAMMO software. Graphs were drawn using WinMGM
(Ab Initio technology, Obernai, France).
3. Results
3.1. Azithromycin alters the morphology of DOPC GUVs
As evidenced by direct microscopic examination, GUVs
prepared by electroformation showed an initial spherical shape
reaching diameter up to ∼50 μm (Fig. 3; 0 s), with b3% of
vesicles below 5 μm. Addition of 50 μM azithromycin induced
reversible fluctuations followed by irreversible loss of the largest
vesicles. First, the membrane showed a rapid phase of budding
and fission followed by reverse fusion (Fig. 3; 10–30 s). In-
complete back fusion eventually resulted into the progressive
disappearance of the largest vesicles within approximately
30 min (Fig. 4A and B). Statistical analysis of size distribution
(Fig. 4C) confirmed that the drug induced the loss of the largest
GUVs with the concomitant increase of smallest vesicles
(centered on 35 μm2 projected area), from ∼40% in controls
to∼60% in azithromycin-treated samples. These morphological
observations indicated that azithromycin preferentially destabi-
lized membranes with the lowest curvature.
3.2. Azithromycin decreases the bending and the elastic
compressibility moduli of DOPC GUVs
As detailed in Materials and methods, the amplitude of
thermal fluctuations of a bilayer is related to its bending elasti-
city, a mechanical property of the membranes gauged by the
bending modulus (kc); the apparent area compressibility mo-
dulus (Kapp) characterizes the energy necessary for the increase
of a bilayer surface area. To determine these parameters, the
values of α and σ were derived from Eqs. (2) and (3), respec-
tively. The bending modulus (kc) was deduced from the slope of
the linear relationship between the logarithm of the tension (σ ˙)
and the relative excess area difference (α) for low values of the
tension. The elastic compressibility modulus (Kapp) was de-
duced from the slope of the linear relationship between ln σ and
α for values of σ above 0.5 mN/m.
The effects of azithromycin on these biophysical param-
eters are shown at low (Fig. 5A) and high σ values (Fig. 5B).
For control vesicles, the bending modulus kc was estimated at
23.1±3.5 kBT; the elastic compressibility modulus, Kapp, was
evaluated at 176±35 mN/m. Upon azithromycin exposure, the
bending modulus, kc, decreased by ∼55% to 10.6±4.5 kBTand the elastic compressibility modulus (Kapp) decreased by
∼35% to 113±25 mN/m, indicating that azithromycin inser-
tion in lipids reduced requirements of both energy for thermal
fluctuations and of stress to stretch the bilayer.
3.3. Molecular simulation of the interaction between
azithromycin and DOPC bilayers
Molecular modeling, explained in details under Materials
and methods, predicted that azithromycin interacts with the
membrane interface of DOPC and induces a modification in the
DOPC organization (compare panels A and B Fig. 6). Struc-
turally, this modification corresponded to an increase in the area
of each lipid molecule, from 68.6 Å2 for pure lipid to 75.9 Å2
when azithromycin was present. It should be noted that the
calculated area for pure DOPC fitted the mean experimental
values [17]. Remarkably, modeling reveals the appearance of a
noticeable space around the azithromycin molecule. Since cal-
culations predicted the azithromycin:DOPC assembly inserted
in an implicit simplified bilayer, this empty space should be
filled with the hydrocarbon chains from the lipids belonging to
the upper layer.
Fig. 6. Assembly of DOPC alone (A) or combined with azithromycin (B)
inserted in the membrane as determined by IMPALA method. Yellow plane=
bilayer centre (z=0); magenta plane=phospholipid acyl chain/polar headgroup
interface at z=13.5 Å from the centre; pink plane=phospholipid:water interface
(z=18 Å). Azithromycin is represented in CPK (Corey–Pauling–Kaltum) mode.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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the interaction energy betweenDOPCmolecules, from−15.5Kcal
mol−1 to −11.5 Kcal mol−1. The energy of interaction between
azithromycin and DOPC was predicted at −33.2 Kcal mol−1.
Taken together, results of this in silico approach indicated that
azithromycin insertion in lipids decreases the energy of interaction
between DOPC molecules and increases the mean surface
occupied by each phospholipid molecule.
4. Discussion
Self assembly of biological structures is an intricate process
where a variety of intermolecular forces interplay. The major
force holding membrane lipid molecules together are the
London–Van der Waals forces. Van der Waals interactions in
general are attractive forces which are not simply based on
electrostatic interactions. They are attributed to electromagnetic
interactions, occurring by fluctuations of charges. These forces,
together with the configurational entropy of the hydrogen bondnetworks, are involved along the acyl chains and are responsible
for the organization of phospholipids into various lyotropic
structures. In addition to this global organization, lipid bilayers
can be characterized by their dynamic equilibrium thermal
fluctuations including stretching and bending deformations.
Lipid: lipid interactions and mechanical properties of mem-
branes, especially bending rigidity, can be affected by incor-
poration of amphiphilic molecules, such as azithromycin, which
perturbs the lipid packing. Recent atomic force microscopy
analysis have revealed that the macrolide antibiotic, azithro-
mycin, lead to an erosion of DPPC gel phase domains in DOPC
fluid phase matrix [1,4].
To further examine if these alterations were related to impair-
ment by azithromycin of membrane elastic properties, especially
those of the bulk fluid phase of DOPC, we here investigated the
effect of this antibiotic on the bending modulus (kc) and the
apparent compressibility modulus (Kapp) using the powerful
micropipette aspiration technique. This approach, originally
developed by Evans et coll. [10,11], has been largely used to
derive biophysical parameters by the analysis of induced de-
formation of large artificial vesicles or living cells. Experimental
determination of elastic moduli have provided major information
about the adhesive properties of cells [18,19] as well as the effect
induced by (i) change in membrane lipid composition [20],
temperature [20] or mechanical stress [21] or (ii) interaction of
exogenous molecules like peptides [22], proteins [23], drugs [24],
or alcohols [25]. Our results using this approach to investigate the
effect of azithromycin on the membrane elastic properties can be
related to the ability of this antibiotic tomodify theDOPCvesicles
shape, as monitored by conventional microscopy, and to the
change of themean surface area occupied by oneDOPCmolecule
together with the energy of interaction between DOPCmolecules,
as predicted in silico after molecular modeling.
Due to their single membrane and large size, giant uni-
lamellar vesicles (GUVs) represent an advantageous model
system mimicking cell membranes for both physical and bio-
logical investigations [10,26,27]. In particular, the low mem-
brane curvature of GUVs better mimics that of flat domains of
the plasma membranes than conventional small vesicles ex-
hibiting a higher curvature. In addition, at low curvature,
stochastic fluctuations should enhance penetration of exoge-
nous molecules [28]. Furthermore, GUVs can be visualized by
conventional microscopical methods and are very sensitive to
environmental parameters such as temperature variations, elec-
tric field, mechanical constraints, local modification of their
composition or insertion of exogenous compounds [29,30], all
of which may affect the energetic equilibrium of the bilayer.
Moreover, studies on individual GUVs provide informations on
their structure and physical properties as an effect of time and
spatial coordinates, that cannot be obtained by the population-
based studies of lipid vesicles in suspension [31].
Conventional microscopy readily showed that addition of
azithromycin immediately triggered visible GUVs fluctuations:
the shape of the vesicles was modified, so that a new energy
minimum would be reached and the vesicle started budding.
However, this change of shape appeared to be not sufficient for
the bilayer to keep a constant minimum energy, and DOPC
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that controls the budding remains uncertain. Flip-flop, which is
extremely slow for phospholipids (half-time of several hours
[32]), is probably not involved in this process. After 30 s, the
bilayer recovered a spherical shape corresponding to the initial
shape (i.e. before the addition of the antibiotic). After a longer
time interval (30 min), the largest GUVs had disappeared. It is
likely that the drug, added outside GUVs, is unable to cross the
membrane bilayer, thus preferentially inserts into the outer
membrane layer and affects the bilayer couple [33]. In this view,
the shape of an individual GUV is determined by the minimum
bending energy for a given area, A, a given volume, V, and a
given area difference between the two monolayers in the bilayer
membrane area, ΔA. In the presence of azithromycin, the in-
crease in the area difference between the two leaflets of the
bilayer, ΔA, without change of V, would lead to a rearrange-
ment of the lipid molecules until destruction of the vesicle.
Since fluctuations of the largest vesicles should lead to consi-
derable movement of the membrane, as indeed shown by mic-
roscopy, a higher proportion of foreign molecules should be
entrapped in the external monolayer and affect the equilibrium
of the entire bilayer, explaining the preferential disappearance
of the largest vesicles.
The effect of azithromycin on the vesicle shape prompted us
to measure the elastic bending constants of lipid bilayers, and
especially, to compare the bending modulus and the apparent
area compressibility modulus in the absence and presence of
azithromycin. The elastic properties of membranes modulate
lipid:lipid interactions [34], and also affect the lateral com-
pressibility [11,35] in a way that might have functional conse-
quences, e.g. for membrane insertion of proteins [23] or drugs
[24,35]. Only very few studies have addressed this possibility.
The bending modulus (kc) of untreated DOPC GUVs was
measured as 23.1±3.5 kBT, in excellent agreement with the
literature [20,36] when taking into consideration that differ-
ences in the mode of preparation of GUVs, in the temperature
during the formation of GUVs, and in the composition of the
buffer can all induce strong discrepancies in the measured
elastic parameters [20,36]. The bending modulus, kc, decreased
two-fold in presence of azithromycin, indicating that insertion
of the antibiotic in the DOPC bilayer reduced the energy
requirements for thermal fluctuations. This decrease could be
due to a modification of the spontaneous curvature and/or to a
higher lateral diffusion of the constituents of the bilayer [36].
This effect was indeed observed together with a higher com-
pressibility of membrane, reflecting that a lower stress is re-
quired to stretch the bilayer (Kapp decreased from 176±35mN/m
in controls, again in good agreement with the literature [36],
down to 113±25 mN/m in presence of azithromycin). Since the
apparent area compressibility modulus (Kapp), is itself related to
the packing of the constituents of the bilayer, its decrease upon
azithromycin must reflect a reduction in the lipid bilayer den-
sity and the smoothing of thermal fluctuations. These changes
could affect the membrane thickness and it should be inter-
esting to further investigate the effect of azithromycin on this
parameter using approaches like Reflection Interference Con-
trast Microscopy (RICM) [37] or X-ray diffraction [38].These conclusions are confirmed independently by in silico
modeling using, the IMPALA restraint field, developed by one of
the authors [16]. This method allows one to study the interactions
between a drug and a lipid bilayer using simple restraint functions
designed to mimic the major properties of the membrane,
including the solvent hydrophobicity and the lipid perturbation.
This approach has been already useful to predict the insertion of
tilted peptide [39] and to design de novo a fusogenic peptidemade
of non-natural aminoacids [40]. Here, we show by molecular
modeling that azithromycin inserts at the interface of lipids.
Remarkably, a noticeable space was observed around the
azithromycin molecule in the lipid monolayer. Since the
calculations on the interaction of azithromycin with DOPC are
made on a monolayer, the empty space around azithromycin
should be filled with the hydrocarbon chains from the lipids
belonging to the upper layer. This cannot be, however, predicted
using the currently modeling approach available. Indeed,
calculations are made in two steps. The first one is to surround
azithromycin with lipid molecules, forming a monolayer. This
monolayer (one layer of lipids+azithromycin) is then positioned
in an implicit bilayer (i.e. only the properties of the bilayer are
simulated by an empirical function, see Methods). Thus, the
physical effect of azithromycinmolecule on the lipid molecules is
only predicted in the monolayer and the effects on the entire
bilayer cannot be evaluated. Combined with experimental data,
our study, however, clearly demonstrates that azithromycin
insertion within the lipid bilayer reduces its cohesion and
increases the mean surface occupied by each lipid molecule.
Micropipette experiments revealed a marked decrease of the
elastic moduli of DOPC lipid bilayers upon exposure to
azithromycin, with both kc and Kapp being strongly affected.
Morphological studies on DOPC GUVs showed that azithromy-
cin leads to the destruction of the largest ones, probably due to
lipid vesicles reorganization. These effects may be due to an
increase of the available space between hydrophobic chains,
enhancing their mobility, in agreement with the partition of
azithromycin within the membrane interface, and to the decrease
of the interaction energy between DOPC molecules in the
presence of azithromycin, as predicted by molecular modeling.
The excellent agreement between theoretical and experimental
approaches also underlines the potency of molecular modeling to
predict the effect of drug insertion on lipid membrane properties.
The decrease of the cohesion of DOPC bilayer induced by
azithromycin antibiotic, as observed in this study, together with
the fluidification of DPPC [4] and the probable preferential
accessibility of azithromycin at the interface between DPPC and
DOPC [41–43], might explain why azithromycin is able to
erode the lipid domains of DPPC and to facilitate the merging of
DPPC gel phase into a DOPC fluid matrix, as observed by
atomic force microscopy [1]. Our findings thus provide new
molecular insights of the interaction between a macrolide anti-
biotic, as drug model, and an artificial lipid membrane, made of
pure DOPC. Since cholesterol markedly affects the membrane
curvature and bending elasticity [44,45], these studies should be
extended to GUVs with more complex lipid composition, for a
better understanding of relevant effects of azithromycin and
other drugs for cellular membranes.
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